Aug 26, 2026 · 9 min
Markets weigh inflation data against Nvidia’s earnings test
Markets' Two-Part Test: Nvidia Earnings, PCE Data
The episode frames one trading session around two forces that could shift rate expectations and determine whether technology stocks can sustain their momentum.
- 1The Federal Reserve’s preferred inflation gauge and GDP data could reshape expectations for interest rates.
- 2Nvidia and several major technology companies report after the close, putting tech-sector momentum under scrutiny.
- 3The market must balance fresh economic signals against earnings evidence from companies driving investor enthusiasm.
Don't miss
Nvidia’s after-hours earnings report becomes the clearest test of whether technology-sector momentum can withstand fresh economic data.
The brief
The Schwab Market Update previews Wednesday, August 26th, when inflation and GDP reports could move interest-rate expectations before a busy technology earnings slate begins.
The Federal Reserve’s preferred inflation gauge is the key economic release, while GDP data offers another read on conditions investors are using to assess policy.
After the market closes, Nvidia, CrowdStrike, Synopsys and Salesforce report results, giving investors fresh evidence on whether technology momentum remains durable.
The episode’s central tension is straightforward: economic data may challenge rate assumptions just as major technology earnings test the market’s appetite for continued growth.
Nvidia anchors the earnings focus, making its report the clearest moment for judging whether enthusiasm around the technology sector still has fundamental support.
What was said on this episode
4 statements · 1 positive · 3 negative
Another GDP downward revision could weaken the case for a hawkish Fed stance.
“Another downward revision could challenge the case for a more hawkish Fed stance.”
Listen at 5:28
Intuit’s weak guidance and slowing revenue growth spooked investors.
“Weaker-than-expected guidance and slowing revenue growth seemingly spooked investors.”
Listen at 6:54
Positive mRNA cancer-vaccine trial results drove enthusiasm for Moderna.
“Moderna continued its run higher, surging 14.4% amid investor enthusiasm about recent positive trial results for the company's mRNA cancer vaccine.”
Listen at 7:10
Dick’s shares fell after missing expectations and issuing weak guidance.
“Dick's Sporting Goods plunged 30.8% after falling short of Wall Street's expectations and offering weaker-than-expected guidance amid disappointing sales at Foot Locker.”
Listen at 7:22
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.